Google Ventures
VC Fund
Mountain View, United States
Google Ventures is a VC fund in Mountain View focused on Software and Health Care. GV invests in sectors including life sciences, consumer, enterprise, crypto, climate, and frontier technology. With Alphabet as its sole limited partner, GV focuses on investments in North America and Europe. Its operating partners assist startups in design, equity, diversity & inclusion, talent, and engineering, and help them connect with Google for technology and expertise. Some investments include Uber, Nest, Slack, GitLab, and One Medical.
- Total investments:
- 1520
- Last investment:
- Lead investor:
- 30%
- Fund size:
- $100M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Google Ventures invests in
Stages Google Ventures invests in
Countries Google Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 24 contacts → | |||
Round size
- Seed
- $1.1M–$15M
- Series A
- $6M–$100M
- Series B
- $15M–$121M
Investment Focus
Industry
- Software 223 (15%)
- Health Care 144 (9%)
- Biotechnology 128 (8%)
- Artificial Intelligence 118 (8%)
- Information Technology 78 (5%)
Stage
- Series A 284 (19%)
- Series B 261 (17%)
- Seed 207 (14%)
- Series C 173 (11%)
- Series D 98 (6%)
Country
- United States 641 (42%)
- United Kingdom 43 (3%)
- Israel 5 (0%)
- Switzerland 4 (0%)
- Canada 3 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Andy Wheeler
Partner
|
Partner | Total investments: 39 | Find email | |
Anika Gupta
Principal
|
Principal | Total investments: 4 | Find email | |
Anthony Philippakis
Venture Partner
|
Venture Partner | Total investments: 26 | Find email | |
Ben Robbins
General Partner
|
General Partner | Total investments: 25 | Find email | |
Bethany Tsui
Principal and Investor
|
Principal and Investor | Total investments: 0 | Find email | |
| See all 24 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets. | $310M / Series C / Oct 15, 2026 | ||
| Allara is a healthcare program that allows patients to access expert, specialty care through virtual appointments. Allara offers a medical provider and a registered dietitian for polycystic ovary syndrome. They provide holistic care, diagnostic testing, prescriptions, video appointments with a medical provider, dietary and lifestyle changes,nutrition counseling, and medication. | $30M / Venture - Series Unknown / Oct 13, 2026 | ||
| Arboretum LifeSciences develops precision medicine programs for common diseases. The company provides genetic testing programs for cardiovascular disease, cancer, and metabolic conditions through healthcare system partnerships. Its research participant platform supports electronic consent, survey collection, biospecimen coordination, research results, and matching to research opportunities. Its research analysis environment stores, curates, and analyzes research data. Arboretum LifeSciences also operates collaborative patient registries and supports clinical trial development based on genetic and health data. | $30M / Series A / Oct 06, 2026 | ||
Armadin Security
|
Armadin Security is an AI-powered cybersecurity company that specializes in real-time threat hunting. | $265M / Series B / Oct 01, 2026 | |
| Metaview is re-engineering hiring with AI at the core. Founded in 2018 by Siadhal Magos and Shahriar Tajbakhsh, former product and engineering leaders at Uber and Palantir, Metaview helps recruiting teams harness AI across every stage of the hiring process, from intake to final offer.They started Metaview to help leaders and operators excel atthe most high-leverage activity in any organization: building great teams. By turning interviews into rich, actionable data, Metaview transforms interviewers into a company’s most valuable asset in the war for talent.Thousands of companies use Metaview to streamline workflows, uncover deeper insights, and make smarter, faster decisions. Backed by top-tier investors and loved by high-performing teams, Metaview is redefining how modern hiring happens. | $60M / Series C / Sep 30, 2026 | ||
| Snorkel AI is a technology startup that empowers data scientists and developers to turn data into accurate and adaptable AI applications fast with Snorkel Flow, a first-of-its-kind data-centric development platform, powered by programmatic labeling. Snorkel Flow reduces the time, cost, and friction of labeling training data so data science anddevelopment teams can more easily build and scale AI models to deploy more meaningful applications. Incorporating human judgment into the AI process through subject-matter experts is made more efficient and scalable leading to more ethical, responsible outcomes.Two out of the top three US banks, several government agencies and Fortune 500 companies use Snorkel Flow. Snorkel’s core research was developed at Stanford AI lab and is deployed at Google, Intel, Apple, IBM, DARPA, and other trailblazing organizations. | $350M / Series E / Sep 22, 2026 | ||
| EnduroSat designs and engineers spacecraft for business applications and space exploration missions. The company focuses on swarm/constellation satellite applications. EnduroSat builds customized satellites and providing complete support service for full-cycle missions. | $205M / Series C / Sep 16, 2026 | ||
| Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. The company's therapy pipeline addresses devastating genetic and acquired disorders spanning multiple disease pathways including neurocircuitry, metabolic disorders, neurodegeneration and cardiovasculardisease, enabling medical practitioners to treat patients and improve their lives. | $275M / Series F / Sep 09, 2026 | ||
| Blacksmith provides cloud infrastructure for continuous integration, enabling developers to build, test, and deploy software. | $45M / Series B / Aug 12, 2026 | ||
| Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. The company's proprietary and patented technologies oriented around deciphering the complexity of biology networks includeboth high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications. | $5M / Venture - Series Unknown / Aug 10, 2026 | ||
| See all 1520 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Google Ventures invest in?
Google Ventures invests primarily in Software, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 1,520 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Google Ventures invest in?
Google Ventures typically joins rounds of $1.1M–$15M at Seed, $6M–$100M at Series A and $15M–$121M at Series B. These are whole funding-round sizes, not Google Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Google Ventures took part in.
How do I contact Google Ventures?
Public channels for Google Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Google Ventures?
The team at Google Ventures includes Andy Wheeler (Partner), Anika Gupta (Principal) and Anthony Philippakis (Venture Partner), among 24 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
